Biofrontera Inc (BFRI) SEC 13F Holdings (Q2 2026): Institutional Buyers & Sellers

BFRI ranks #8522 out of 37503 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

BFRI is a disclosed holding of Jim Simons (Renaissance Technologies), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

19 institutions disclose a position in BFRI, but none treat it as a major bet — even Rosalind Advisors, Inc., its most concentrated holder, allocates just 0.5% of its own portfolio to it.

Rosalind Advisors, Inc. has added to its BFRI position for two straight quarters, increasing it by $555.9K to reach $1.2M today.

BFRI reported a net loss of $6.4M over the trailing twelve months.

• Not yet profitable — net loss of $6.4M over the trailing twelve months
• Revenue grew 17.8% year over year
• Net income improved year over year, from -$16.6M to -$6.4M
• Operating cash flow was negative, using $13.4M in cash
• Current ratio of 1.52x — enough short-term assets to cover short-term liabilities
• Liabilities run 1507.00x equity — a highly leveraged balance sheet worth noting